USFDA completes inspection of Lupin’s Vizag API manufacturing facility

18 Jan 2020 Evaluate

United States Food and Drug Administration (USFDA) has completed inspection at Lupin’s Vizag API manufacturing facility. The inspection was carried out between January 13, 2020 and January 17, 2020. The inspection for the API facility at Vizag closed with five 483 observations.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

1613.90 5.55 (0.35%)
16-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1536.95
Dr. Reddys Lab 6038.00
Cipla 1384.30
Zydus Lifesciences 937.80
Lupin 1613.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.